Moroxydine hydrochloride
Moroxydine hydrochloride structure
|
Common Name | Moroxydine hydrochloride | ||
|---|---|---|---|---|
| CAS Number | 3731-59-7 | Molecular Weight | 171.20000 | |
| Density | 1.51 g/cm3 | Boiling Point | 327ºC at 760 mmHg | |
| Molecular Formula | C6H13N5O | Melting Point | 211-214 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 151.6ºC | |
| Symbol |
GHS07 |
Signal Word | Warning | |
|
[The efficacy of a combined therapy against herpes virus genital infections].
Rev. Roum. Virol. 43(3-4) , 201-6, (1992) A complex immuno-chemical therapy (inhibition of viral replication, stimulation of cell mediated immunity, interferon induction) was applied to 75 patients with herpes virus genital infections. Treatment was followed by complete recovery in 66.7% of the subje... |
|
|
Immunologic and antiviral therapy in herpetic keratitis.
Roum. Arch. Microbiol. Immunol. 51(4) , 233-7, (1992) A group of 113 patients with herpetic keratitis who were administered besides the classical therapy (local and general) immunologic and antiviral treatments was studied. The following Romanian non-toxic preparations were used: "SRE Immunostimulent", "Moroxidi... |
|
|
Synthesis and molecular mechanical studies of antiviral copper(II) complexes with morpholinebiguanide drug.
Roum. Arch. Microbiol. Immunol. 57(3-4) , 279-93, (1998) The synthesis and characterization of new Cu(II) complexes with morpholinebiguanide drug are described. The complexes formed have been characterized by elemental analysis, IR, UV-VIS, conductance measurements, EPR spectra and magnetic susceptibility measureme... |
|
|
Prospective study of a phenformin-like substance (moroxydine chloride) in patients with deficient vessel wall fibrinolysis.
J. Med. 13(5-6) , 353-64, (1982) It is known that ethylestrenol and/or phenformin can normalize deficient fibrinolysis in the vessel walls and prevent recurrent thromboembolism (Hedner et al., 1976; Nilsson et al., 1975, 1981). Because of the side-effects of phenformin, we studied the effect... |
|
|
Failure of the biguanide moroxydine chloride to stimulate plasma fibrinolytic activity.
Acta Med. Scand. 215(3) , 221-4, (1984) Eleven patients with recurrent venous thrombosis or thrombophlebitis and a decreased fibrinolytic activity after venous occlusion were given a phenformin-like substance, moroxydine chloride, for 6 months. No sustained increase in the fibrinolytic activity was... |
|
|
Use of a low-molecular weight heparin (enoxaparin) or of a phenformin-like substance (moroxydine chloride) in primary early recurrent aborters with an impaired fibrinolytic capacity.
Thromb. Haemost. 73(3) , 362-7, (1995) An impaired fibrinolytic capacity, defined as an insufficient venous occlusion-induced shortening of the plasma euglobulin clot lysis time, is a common feature in women suffering from primary early recurrent unexplained miscarriages. We investigated the thera... |
|
|
Determination of moroxydine in biological fluids by electron-capture gas chromatography.
J. Chromatogr. A. 229(1) , 227-33, (1982)
|
|
|
[Antiviral drugs].
Rev. Prat. 35(47) , 2867-71, (1985)
|
|
|
[Chemotherapy of virus diseases].
Internist (Berl.) 24(11) , 619-26, (1983)
|
|
|
Moroxydine: the story of a mislaid antiviral.
Acta Derm. Venereol. Suppl. (Stockh.) 183 , 1-9, (1994) A review is presented which began as a literature survey listing verbatim over fifty abstracts and references to the use of moroxydine in the treatment of a number of viral disorders throughout Europe and Scandinavia between 1960 and 1985. The list was first ... |